Forensic Analyst, Trudence Capital Advisors

Nitin Mangal

Forensic Analyst

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

Forensic Accounting

Affle 3i Limited is a global technology company that provides a consumer intelligence platform, delivering consumer engagements, acquisitions, and transactions through mobile advertising. The company operates on a Cost Per Converted User (CPCU) model, transforming online and offline user data into actionable insights for brands. It was incorporated in 1994 and is headquartered in Gurugram, India.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/affle-3i-limited" target="_blank" data-smartkarma-citation="entities:28934:1" rel="noopener">Affle 3i (AFFLE IN)</a> 's revenue recognition accounting differs from the peers despite same business model. Rising unbilled revenues coupled with a sharp increase in bad debts strike concerns.</li>
<li>Affle’s capitalisation rate of product-development costs has also increased over the last five years; standing above peers and supporting margins amidst slowdown in revenue growth.</li>
<li>Accounting prudence also remains under question for acquisitions. Investment in Bobble continues to be carried in full despite impairment risks while Appnext’s restructuring is interesting amid losses.</li>
</ul>



Affle 3i (AFFLE IN) 's revenue recognition accounting differs from the peers despite same business model. Rising unbilled revenues coupled with a sharp increase in bad debts strike concerns.
Affle’s capitalisation rate of product-development costs has also increased over the last five years; standing above peers and supporting margins amidst slowdown in revenue growth.
Accounting prudence also remains under question for acquisitions. Investment in Bobble continues to be carried in full despite impairment risks while Appnext’s restructuring is interesting amid losses.


Aether Industries is an Indian specialty chemical manufacturer that produces advanced intermediates and specialty chemicals for various industries, including pharmaceuticals, agrochemicals, material sciences, and oil & gas. The company operates through large-scale manufacturing, contract research and manufacturing services (CRAMS), and contract/exclusive manufacturing business models. It was founded in 2013 and is headquartered in Surat, Gujarat, India.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/aether-industries-ltd" target="_blank" data-smartkarma-citation="entities:36096:1" rel="noopener">Aether Industries (AETHER IN)</a> ’s INR20.6 bn capex cycle is now yielding strong growth and 31.3% EBITDA margins; however, reported profitability is partly influenced by accounting judgements w.r.t. fire incidents.</li>
<li>Underlying cash conversion remains weak at 39% of adjusted EBITDA over FY20–FY26, further questioning the earnings quality.</li>
<li>Execution delays, promoter-linked transactions and unusual cost allocation at ASCL introduce additional questions that need explanation.</li>
</ul>



Aether Industries (AETHER IN) ’s INR20.6 bn capex cycle is now yielding strong growth and 31.3% EBITDA margins; however, reported profitability is partly influenced by accounting judgements w.r.t. fire incidents.
Underlying cash conversion remains weak at 39% of adjusted EBITDA over FY20–FY26, further questioning the earnings quality.
Execution delays, promoter-linked transactions and unusual cost allocation at ASCL introduce additional questions that need explanation.


Aether Industries Ltd: The Other Side of Growth

Jubilant Ingrevia Limited is a global integrated life science products and innovative solutions provider. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers with specialty chemicals, nutrition and health solutions, and chemical intermediates. It offers a broad portfolio of high-quality ingredients and provides custom development and manufacturing services for pharmaceutical and agrochemical clients. Jubilant Ingrevia is headquartered in Noida, Uttar Pradesh, India, and was incorporated on October 23, 2019.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/jubilant-ingrevia-ltd" target="_blank" data-smartkarma-citation="entities:45231:1" rel="noopener">Jubilant Ingrevia (JUBLINGR IN)</a> ’s Business Mix is improving with Specialty Chemicals driving 75% of EBITDA; however, capital efficiency remains subdued as asset turnover and ROCE have yet to recover.</li>
<li>Balance-Sheet health remains comfortable, but capital allocation warrants scrutiny given excess cash in current accounts, rising contingent liabilities and potential under-utilisation of newly commissioned Bharuch capacity. </li>
<li>Earnings quality has watchpoints, including rising receivables, sizeable non-core income, profit-linked promoter remuneration and nominal-priced ESOPs, though no strong aggregate manipulation signal emerges.</li>
</ul>



Jubilant Ingrevia (JUBLINGR IN) ’s Business Mix is improving with Specialty Chemicals driving 75% of EBITDA; however, capital efficiency remains subdued as asset turnover and ROCE have yet to recover.
Balance-Sheet health remains comfortable, but capital allocation warrants scrutiny given excess cash in current accounts, rising contingent liabilities and potential under-utilisation of newly commissioned Bharuch capacity. 
Earnings quality has watchpoints, including rising receivables, sizeable non-core income, profit-linked promoter remuneration and nominal-priced ESOPs, though no strong aggregate manipulation signal emerges.


Jubilant Ingrevia- Transformation with Some Caveats

All Time Plastics Limited manufactures plastics products. The Company offers mugs, storage and laundry baskets, hangers, bathroom sets, thermos, bottles, and other plastic houseware products. All Time Plastics serves customers in India.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/all-time-plastics-limited" target="_blank" data-smartkarma-citation="entities:55510:1" rel="noopener">All Time Plastics (ALLTIME IN)</a> delivered steady growth with resilient gross margins; however, FY26 profitability weakened as geopolitical headwinds and capacity additions increased overheads, while utilisation remained subdued.</li>
<li>FY25 receivables surged 79% despite 9% revenue growth, though normalised subsequently; recurring discrepancies between books and bank-reported working capital raise concerns over periodic reporting and reconciliation controls.</li>
<li>Governance warrants attention given sizeable pre-IPO property purchases from promoters, high promoter/KMP remuneration and an unexplained INR 150 mn corporate loan.</li>
</ul>



All Time Plastics (ALLTIME IN) delivered steady growth with resilient gross margins; however, FY26 profitability weakened as geopolitical headwinds and capacity additions increased overheads, while utilisation remained subdued.
FY25 receivables surged 79% despite 9% revenue growth, though normalised subsequently; recurring discrepancies between books and bank-reported working capital raise concerns over periodic reporting and reconciliation controls.
Governance warrants attention given sizeable pre-IPO property purchases from promoters, high promoter/KMP remuneration and an unexplained INR 150 mn corporate loan.


All Time Plastics- Few Cracks in the Mould

Equity Capital Markets

Zepto offers a 10-minute grocery delivery service through an e-grocery app that revolutionizes the grocery buying experience.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/geddit-convenience-pvt-ltd-zepto" target="_blank" data-smartkarma-citation="entities:35873:1" rel="noopener">Zepto (1936629D IN)</a> has scaled aggressively to INR 226 bn revenue and 1,139 dark stores by FY26; however, adj.EBITDA losses remain elevated at INR 54 bn despite improving unit economics.</li>
<li>Despite improving unit economics, profitability remains fragile; lower marketing intensity and the commencement of technology and post-opening store-cost capitalisation in FY26 have also supported reported EBITDA improvement.</li>
<li>Pre-IPO restructuring materially altered retained earnings. Litigation liabilities, high attritions, asset write offs, unbilled revenues, warrant additional scrutiny.</li>
</ul>



Zepto (1936629D IN) has scaled aggressively to INR 226 bn revenue and 1,139 dark stores by FY26; however, adj.EBITDA losses remain elevated at INR 54 bn despite improving unit economics.
Despite improving unit economics, profitability remains fragile; lower marketing intensity and the commencement of technology and post-opening store-cost capitalisation in FY26 have also supported reported EBITDA improvement.
Pre-IPO restructuring materially altered retained earnings. Litigation liabilities, high attritions, asset write offs, unbilled revenues, warrant additional scrutiny.


Nitin Mangal is a Research Analyst with more than 15 years of experience in Indian equities. He is Pioneer of Corporate Governance and Accounting Research in Indian Market and has successfully developed product for Institutional Investors named as "Analysis Beyond Consensus" during his association with Edelweiss Securities Ltd, Mumbai. Later during the career, he has worked with Veritas Investment Research Corporation, Canada as Asia Consultant covering Indian and US equities. He has been profiled by leading financial newspapers such as Wall Street Journal, Business Standard etc